Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/gutjnl-2016-313565 http://scihub22266oqcxt.onion/10.1136/gutjnl-2016-313565 C5878048!5878048 !28487442     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28487442 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Gut 2017 ; 66 (7 ): 1329-1340 Nephropedia Template TP {{tp|p=28487442 |t=2017. CRISPR/Cas9: at the cutting edge of hepatology |pdf=|usr=}}{{28487442 }} gab.com Text CRISPR/Cas9: at the cutting edge of hepatology JO: Gut http://www.kidney.de/pget.php?&tw=1&pmid=28487442 #FOAvip Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 genome engineering has revolutionised biomedical science and we are standing on the cusp of medical transformation. The therapeutic potential of this technology is tremendous, however, its translation to the clinic will be challenging. In this article, we review recent progress using this genome editing technology and explore its potential uses in studying and treating diseases of the liver. We discuss the development of new research tools and animal models as well as potential clinical applications, strategies and challenges. Twit Text FOAVip CRISPR/Cas9: at the cutting edge of hepatology ????Gut http://www.kidney.de/pget.php?&tw=1&pmid=28487442 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28487442 #FOAvip English Wikipedia <ref>{{Cite pmid|28487442 }}</ref> CRISPR/Cas9: at the cutting edge of hepatology #MMPMID28487442 Pankowicz FP ; Jarrett KE ; Lagor WR ; Bissig KD Gut 2017[Jul]; 66 (7 ): 1329-1340 PMID28487442 show ga Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 genome engineering has revolutionised biomedical science and we are standing on the cusp of medical transformation. The therapeutic potential of this technology is tremendous, however, its translation to the clinic will be challenging. In this article, we review recent progress using this genome editing technology and explore its potential uses in studying and treating diseases of the liver. We discuss the development of new research tools and animal models as well as potential clinical applications, strategies and challenges. |*CRISPR-Cas Systems [MESH] |*Gene Editing [MESH] |Animals [MESH] |Clustered Regularly Interspaced Short Palindromic Repeats/genetics [MESH] |Gene Targeting [MESH] |Gene Transfer Techniques [MESH] |Genetic Therapy [MESH] |Hepatitis B virus/genetics [MESH] |Humans [MESH] |Mutagenesis [MESH] |Mutation [MESH]CRISPR/Cas9: at the cutting edge of hepatology (epmc).pdf DeepDyve Pubget Overpricing